RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Gross margin (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.05T
P/E ratio
22.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202581.7-0.03%
Mar 31, 202481.8+0.93%
Mar 31, 202381+0.66%
Mar 31, 202280.5+0.21%
Mar 31, 202180.3+2.01%
Mar 31, 202078.7+1.39%
Mar 31, 201977.6+147.50%
Mar 31, 201831.4+7.80%
Mar 31, 201729.1+4.42%
Mar 31, 201627.9-3.49%
Mar 31, 201528.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)